Choledochoscope Market Global Report 2026

The choledochoscope market size has grown strongly in recent years. It will grow from $0.68 billion in 2025 to $0.74 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising incidence of gallbladder and bile duct disorders, increasing adoption of minimally invasive surgical procedures, advancements in endoscopic imaging technologies, growth in hospital surgical infrastructure, increasing awareness of early diagnosis of biliary diseases.

The choledochoscope market size is expected to see strong growth in the next few years. It will grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to integration of AI-guided surgical visualization systems, expansion of robotic-assisted gastrointestinal procedures, growth in outpatient minimally invasive surgeries, development of high-definition flexible endoscopy systems, and increasing investment in advanced surgical training technologies. Major trends in the forecast period include AI-assisted choledochoscopy imaging and navigation systems, robotic-assisted bile duct endoscopy platforms, IoT-enabled smart surgical endoscopy devices, cloud-based endoscopic data storage and diagnostic analytics, and Industry 4.0-enabled precision manufacturing of endoscopes.

The increasing preference for minimally invasive procedures is anticipated to drive the growth of the choledochoscope market in the coming years. Minimally invasive procedures are medical techniques that utilize small incisions or natural body openings along with specialized instruments to minimize tissue injury, reduce pain, and shorten recovery time compared to traditional open surgeries. The rising adoption of minimally invasive procedures is primarily attributed to their ability to ensure quicker patient recovery, reduced pain, and shorter hospital stays due to limited tissue damage. A choledochoscope facilitates minimally invasive procedures by enabling direct visualization and intervention within the bile ducts through small incisions or natural openings, allowing surgeons to diagnose and extract stones or clear obstructions without the need for open surgical procedures. For instance, in September 2023, according to the National Library of Medicine, a US-based federal government agency, as of 2023, 7,733 robotic surgical systems were installed worldwide, and more than 10 million robotic surgeries have been performed. Therefore, the increasing preference for minimally invasive procedures is driving the growth of the choledochoscope market.

The rising healthcare expenditure is expected to drive the growth of the choledochoscope market in the future. Healthcare expenditure refers to the total financial resources allocated by individuals, organizations, or governments toward the prevention, treatment, and management of health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatment options, and innovative therapies often involve higher costs, thereby increasing overall healthcare spending. Healthcare expenditure supports the adoption of choledochoscopes by enabling healthcare facilities to invest in advanced minimally invasive endoscopic systems for improved diagnosis and treatment of biliary diseases. For instance, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, in 2024, the UK’s healthcare spending reached approximately $372.31 billion (£317 billion), representing a 6.5% nominal increase compared to 2023. Therefore, the rising healthcare expenditure is driving the growth of the choledochoscope market.

In March 2023, Boston Scientific Corporation, a US-based medical technology company, partnered with Scivita Medical Technology Co. Ltd. to commercialize and distribute a single-use percutaneous choledochoscope in China. Through this partnership, the companies aim to introduce single-use choledochoscopes in the Chinese market and enhance the commercialization of biliary endoscopy technologies. Scivita Medical Technology Co., Ltd. is a China-based medical device company that manufactures single-use choledochoscopes for minimally invasive biliary procedures.

Major companies operating in the choledochoscope market are Fujifilm Holdings Corporation, Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Ambu A/S, Cook Medical LLC, KARL STORZ SE & Co. KG, Pentax Medical, Richard Wolf GmbH, Micro Tech Endoscopy USA Inc., SonoScape Medical Corp, Aohua Endoscopy Co Ltd., Zhejiang Soudon Medical Technology Co. Ltd., Scivita Medical Technology Co. Ltd., Zhuhai Pusen Medical Technology Co. Ltd., Zhuhai Seesheen Medical Technology Co. Ltd., HugeMed Medical, Otu Medical, Shanghai Seegen Optoelectronics Technology Co. Ltd., YSENMED.

North America was the dominant region in the choledochoscope market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in choledochoscope report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the choledochoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The choledochoscope market consists of sales of stone retrieval baskets, biopsy forceps and cytology brushes, and laser or electrohydraulic lithotripsy probes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The choledochoscope market research report is one of a series of new reports that provides choledochoscope market statistics, including choledochoscope industry global market size, regional shares, competitors with a choledochoscope market share, detailed choledochoscope market segments, market trends and opportunities, and any further data you may need to thrive in the choledochoscope industry. This choledochoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.